Top compounds associated with response to OR14C36


Feature Type Standardized
Nominal ANOVA
mRNA GDC-0941 gCSI pan-cancer AAC -0.0031 1
mRNA CIL56 CTRPv2 pan-cancer AAC 0.0024 1
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0016 1
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC -0.0037 1
mRNA istradefylline CTRPv2 pan-cancer AAC 0.0026 1
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0017 1
mRNA TGX221 GDSC1000 pan-cancer AAC 0.0022 1
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0015 1
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.0014 1
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.0015 1
Download CSV